Production (Stage)
Ekso Bionics Holdings, Inc.
EKSO
$0.2798
$0.00120.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.89M | -3.41M | -2.07M | -2.42M | -3.43M |
| Total Depreciation and Amortization | 378.00K | 398.00K | 407.00K | 397.00K | 406.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -202.00K | 1.61M | -144.00K | 426.00K | 509.00K |
| Change in Net Operating Assets | 750.00K | -28.00K | -468.00K | -1.08M | -952.00K |
| Cash from Operations | -1.97M | -1.43M | -2.28M | -2.67M | -3.47M |
| Capital Expenditure | -10.00K | -21.00K | -8.00K | 0.00 | -8.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -10.00K | -21.00K | -8.00K | 0.00 | -8.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -313.00K | -312.00K | -313.00K | -312.00K | -313.00K |
| Issuance of Common Stock | 3.84M | -- | 5.00M | 47.00K | 3.97M |
| Repurchase of Common Stock | -- | -2.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.53M | -314.00K | 4.69M | -265.00K | 3.66M |
| Foreign Exchange rate Adjustments | 7.00K | -31.00K | 1.00K | 21.00K | -22.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.56M | -1.80M | 2.41M | -2.91M | 161.00K |